PharmSource has released an extensive study on the supply and demand for contract injectable manufacturing through 2019. The analysis provides information on the latest trends for outsourcing of commercially approved injectable products.   The report leverages PharmSource’s Strategic Advantage Database of Contract Service Providers and provides projections for key processing capabilities, including aseptic fill, lyophilized vials and prefilled devices such as syringes, cartridges and proprietary...